News - Pharmaceuticals
Bayer and UNSW back the next generation of STEM innovators

Bayer Australia and AIESEC at the University of New South Wales (UNSW) have joined forces to launch the Innovation for Impact STEM Case Competition, challenging emerging scientists and engineers to develop novel solutions to the growing impact of climate change on Australian agriculture and human health.
The initiative will bring together aspiring STEM professionals to examine how a changing climate could affect Australia’s $100 billion agricultural industry and shape the future of health. Participating students will develop and pitch innovative solutions to the challenge set out by Bayer, a global company operating at the intersection of healthcare and agriculture.
The winning team will receive sponsorship to attend the Health First STEMM Careers Forum on 18 February 2027 in Sydney, where students will be accompanied and mentored by Bayer leaders. The opportunity is designed to provide access to industry expertise, career insights and professional mentoring that undergraduate students might not ordinarily encounter.
“As a company that is focused on the two greatest challenges facing humanity – health and hunger – we have a responsibility to the next generation of innovators,” said Manoj Saxena, Managing Director of Bayer ANZ Pharmaceuticals. “Overcoming real obstacles in the real world requires students to not only master the fundamental disciplines they learn at university, but also to be able to translate what they know into practical solutions. Bayer is proud to partner with AIESEC at UNSW, to inspire ideas that can generate true impact for the students and the world.”
The competition comes at a time when Australian agriculture faces mounting pressure from rising temperatures, prolonged dry spells and increasingly frequent extreme weather events. Beyond its contribution to the national economy, the sector sustains regional and rural communities, supports food security and supplies raw materials essential to industries ranging from biofuels to pharmaceuticals.
The challenge will focus on four categories of Australian agricultural output, selected for their economic significance and their direct connections to human health and nutrition. Students must propose an implementable solution addressing the effects of rising global temperatures on one of the following:
- Cotton, whose fibre and cellulose are used in wound dressings, swabs and medical textiles, while its seed is processed into cooking oil and stockfeed.
- Wheat, barley or canola, staple agricultural crops that also serve biofuel and industrial markets.
- Fruit and vegetables, which generate significant export revenue and remain central to nutrition in Australia and overseas.
- Medicinal crops such as poppy, with Tasmania alone supplying almost half the world’s licit alkaloid material used in pain relief medicines.
Bayer Sustainability Reporting Manager Dr Jana Phan said the sector’s contribution to Australian livelihoods and the wider economy makes its long-term resilience a matter of national importance.
“Agriculture fundamentally underpins Australian lives and livelihoods,” said Dr Phan. “Aussie farms contribute so much – jobs, food, exports and, in some cases, even the raw materials for medicines. As growing conditions become more adverse, our ability to increase crop yields and protect the industry’s viability depends on research. As STEM students are designing their career paths, we aspire to see agricultural science ranking high in their consideration set.”
The environmental and economic stakes are substantial. With 57% of Australia’s land privately owned or leased for agricultural production, farmers carry both a social responsibility and a strong economic incentive to protect the natural capital on which their businesses depend. Yet climate change is placing increasing strain on both the health of the natural environment and farmers’ financial resources, making effective stewardship more challenging and costly.
Alongside the professional development opportunity, the competition winning team will receive a signed copy of Our Sunburnt Country by Australian agricultural scientist, farmer and climate advocate Dr Anika Molesworth, a recognised advocate for climate resilience who has earned numerous distinctions, including being a finalist for NSW Young Australian of the Year. Combining personal stories with scientific insight, the book examines how climate change is transforming agriculture and explores the role the next generation of scientists can play in building a more resilient food system.
Bayer ANZ Managing Director for Consumer Health Ayumi Uyeda said engaging young people in practical scientific problem-solving could open new avenues for innovation.
“Research increasingly shows that young people can bring a distinctive advantage to innovation because they are often less constrained by established assumptions, professional norms and accumulated experience,” commented Uyeda. “I’m excited by the bold possibilities that can come from solving real problems with science that surprises, and the chance to be inspired by exploring new solutions with fresh minds.”
AIESEC Branch Manager Steven Su added, “Through Innovation for Impact, STEM students tackle real-world business challenges while building the problem-solving, communication and leadership skills they need for the future. We are proud to partner with Bayer to bring this experience to students at UNSW and hope it inspires them to realise the power they have to change the world around them.”
The competition will culminate in the AIESEC* at UNSW Case Competition Live Finals on 24 October 2026, when finalists are scheduled to present their proposals. Bayer ANZ leaders will form part of the judging panel and select the winning team.
*A global youth-led organisation that develops leadership through practical experiences and cross-cultural collaboration
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News - MedTech & Diagnostics
Roche unlocks new horizons for genomic research in Asia Pacific
Roche is advancing its next-generation sequencing (NGS) ambitions in Asia Pacific following the global launch of AXELIOS 1 in June […]
MoreNews - Pharmaceuticals
‘Unexpected and surprising’: Novartis Lp(a) setback raises tough questions for Amgen and Lilly
The failure of Novartis’ lipoprotein(a) [Lp(a)] therapy to translate substantial biomarker reductions into meaningful cardiovascular benefits has been met with […]
MoreNews - MedTech & Diagnostics
More public hospitals turn to same-day hip and knee surgery, but key blind spots persist
Same-day hip and knee replacements to ease surgical waiting lists are being trialled at The Royal Adelaide Hospital (RAH), but […]
MoreNews - Pharmaceuticals
TGA approves oral Wegovy, prompting questions over efficacy and clinical positioning
The Therapeutic Goods Administration (TGA) approval of Novo Nordisk’s oral GLP-1 receptor agonist Wegovy (semaglutide) is introducing a new dimension to […]
More